API 1.01% $1.47 australian pharmaceutical industries limited

dow jones....target 3.20

  1. 11,020 Posts.
    lightbulb Created with Sketch. 65
    [Dow Jones]STOCK CALL¨ Merrill says Sigma's (SIP.AU) increased bid for API (API.AU) would add about 4-8% to EPS in the first full year. "We believe the updated bid speaks of SIP's motivation to proceed," it says in a client note. "Despite the increased bid, we believe API board approval will require an offer that is partly funded with SIP scrip." The new bid may flush out any other potential bidders, it says. Approval from the antitrust regulator is pivotal, Merrill says. "However, following a range of discussions with industry contacts and other experts, we believe that the acquisition is likely to receive ACCC approval. Our experience suggests a 70% likelihood of success." Keeps API buy recommendation, A$3.20 price target. Last trade A$2.62. (ABH)

watchlist Created with Sketch. Add API (ASX) to my watchlist
(20min delay)
Mkt cap ! $724.2M
Open High Low Value Volume
$1.48 $1.50 $1.47 $1.631M 1.100M

Buyers (Bids)

No. Vol. Price($)
9 97940 $1.47

Sellers (Offers)

Price($) Vol. No.
$1.48 129639 5
View Market Depth
Last trade - 16.10pm 23/09/2021 (20 minute delay) ?
-0.015 ( 0.43 %)
Open High Low Volume
$1.49 $1.50 $1.47 147730
Last updated 15.59pm 23/09/2021 (live) ?
API (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.